References
- Alban S, Classen B, Brunner G, Blaschek W (2002): Differentiation between the complement modulating effects of an arabinogalactan-protein from Echinacea purpurea. and heparin. Planta Med 68: 1118–1124.
- Beuscher N, Kopanski L, Ernwein C (1987): Modulation of immune response by polymeric substances from Baptisia tinctoria. and Echinacea angustifolia.. Immunomodulators and non-specific host defence mechanisms against microbial infections. Adv Biosci 68: 329–336.
- Beuscher N, Scheit KH, Bodinet C, Egert D (1990): Modulation of host resistance by polymeric substances from Baptisia tinctoria. and Echinacea purpurea.. Immunotherapeutic. In: Masihi KN, Lange W, eds., Prospects of Infectious Diseases 1st ed., Berlin, Springer-Verlag, pp. 59–63.
- Blaschek W, Döll M, Franz G (1998): Echinacea-Polysaccharide. Z Phytother 19: 255–262.
- Bodinet C, Willigmann I, Beuscher N (1993): Host-resistance increasing activity of root extracts from Echinacea. species. Planta Med 59: A672–A673.
- Brovelli EA, Rua D, Roh-Schmidt H, Chandra A, Lamont E, Noratto GD (2005): Human gene expression as a tool to determine horticultural maturity in a bioactive plant (Echinacea purpurea. L. Moench). J Agric Food Chem 53: 8156–8161.
- Classen B, Witthohn K, Blaschek W (2000): Characterization of an arabinogalactan-protein isolated from pressed juice of Echinacea purpurea. by Yariv reagent. Carbohydr Res 327: 497–504.
- Dalby-Brown L, Barsett H, Landbo AK, Meyer AS, Molgaard P (2005): Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea. on in vitro. oxidation of human low-density lipoproteins. J Agric Food Chem 53: 9413–9423.
- Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F (1956): Colorimetric method for determination of sugars and related substances. Anal Chem 28: 350–356.
- Emmendorffer AC, Wagner H, Lohmann-Matthes ML (1999): Immunologically active polysaccharides from Echinacea purpurea. plant and cell cultures. In: Wagner H, ed., Immunomodulatory Agents from Plants. Basel, Birkhäuser, pp. 89–103.
- Gafner S, Bergeron C, Keil J, Batcha LL, Angerhofer CK (2001): Comparison of extraction efficiency of 50% ethanol versus 65% glycerin: HPLC analysis of Echinacea purpurea. (L.) Moench, Ginkgo biloba. L., Hypericum perforatum. L., Panax quinquefolius., L. and Valeriana officinalis. L. American Society of Pharmacognosy Annual Meeting, New Brunswick, NJ.
- Giori A, Anelli A, Morazzoni P, Di Pierro F (2005): Echinacea angustifolia. extracts. U.S. Patent no. 6,881,426.
- Luettig B, Steinmuller C, Gifford GE, Wagner H, Lohmann-Matthes ML (1989): Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea.. J Natl Cancer Inst 81: 669–675.
- Proksch A, Wagner H (1987): Structural analysis of a 4-O.-methyl-glucuronoarabinoxylan with immuno-stimulating activity from Echinacea purpurea.. Phytochemistry 26: 1989–1993.
- Roesler J, Steinmuller C, Kiderlen A, Emmendorffer A, Wagner H, Lohmann-Matthes ML (1991a): Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea. to mice mediates protection against systemic infections with Listeria monocytogenes. and Candida albicans.. Int J Immunopharmacol 13: 27–37.
- Roesler J, Emmendorffer A, Steinmuller C, Luettig B, Wagner H, Lohmann-Matthes ML (1991b): Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea. to test subjects mediates activation of the phagocyte system. Int J Immunopharmacol 13: 931–941.
- See DM, Broumand N, Sahl L, Tilles JG (1997): In vitro. effects of Echinacea. and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 35: 229–235.
- Steinmüller C, Roesler J, Grottrup E, Franke G, Wagner H, Lohmann-Matthes ML (1993): Polysaccharides isolated from plant cell cultures of Echinacea purpurea. enhance resistance of immunosuppressed mice against systematic infections with Candida albicans. and Listeria monocytogenes.. Int J Immunopharmacol 15: 605–614.
- Stimpel M, Proksch A, Wagner H, Lohmann-Matthes ML (1984): Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea.. Infect Immun 4: 845–849.
- Stuart DL, Wills RBH, Dickeson TM (2004): Optimisation of Polysaccharides in Processed Echinacea purpurea. RIRDC publication. No. 04/118. Barton, Australia.
- Stuppner H (1985): Chemische und Immunologische Untersuchungen von Polysacchariden us der Gewebekultur von Echinacea purpurea. (L.) Moench. PhD thesis, Ludwig-Maximilians-Universität, Munich, Germany.
- Wagner H, Proksch A, Riess-Maurer I, Vollmar A, Odenthal S, Stuppner H, Jurcic K, Le Turdu M, Fang JN (1985): Immunostimulating action of polysaccharides (heteroglycans) from higher plants. Arzneimittelforschung 35: 1069–1075.
- Wagner H, Stuppner H, Schafer W, Zenk M (1988): Immunologically active polysaccharides of Echinacea purpurea. cell cultures. Phytochemistry 27: 119–126.
- Wichtl M (2002): Echinacea angustifolia radix. Herbal Drugs and Phytopharmaceuticals 3rd ed, Boca Raton, CRC Press, pp. 179–182.
- Young CS, Dolan JW (2004): Success with evaporative light-scattering detection, part II: Tips and techniques. LC. GC Europe 17: 192–199.